Vaccine Stocks Gained in Morning Trading

Tiger Newspress2022-09-27

Vaccine Stocks Gained in Morning Trading.

Novavax stock rebounded nearly 12% after Covid-19 vaccines launch in U.K.

The Novavax vaccine is a protein-based vaccine administered as two shots given three weeks apart.

"With U.K. data showing that people infected with both Covid-19 and the flu are more than five times as likely to die compared with someone with no infection, it is more important than ever to consider any vaccine offered to you by the National Health Service," Novavax CEO Stanley Erck said in the news release.

"We continue to believe in the importance of a diversified national vaccine portfolio to reduce winter pressures on the health service," Erck added.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • ececec
    2022-09-28
    ececec
    [Salute] 
  • Tanyl
    2022-09-27
    Tanyl
    Invest all in buy call option
  • 来人
    2022-09-27
    来人
    Ok
  • LuckyPiggie
    2022-09-27
    LuckyPiggie
    Nvax will make many people cry [LOL]  ... like a meme stock
  • neoh
    2022-09-27
    neoh
    Like
Leave a comment
5